Vitamin D Level in Recurrent PV

• Conditions: Recurrent Pityriasis Versicolor

• Registration Number: NCT05067699
• Lead Sponsor: Kasr El Aini Hospital

Brief Summary

Serum Samples will be taken from patients with recurrent Pityriasis Versicolor for the evaluation of vitamin D level.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-09
• Study Start: 2021-09-01
• Study First Submitted: 2021-09-24
• Study First Submitted QC: 2021-09-24
• Last Update Submitted: 2021-09-24
• Study First Posted: 2021-10-05
• Last Update Posted: 2021-10-05
• Primary Completion: 2022-01-01
• Study Completion: 2022-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• • Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it.
• Patients of both genders.
• Age ≥18 years old.

Exclusion Criteria

• • Patients with other cutaneous diseases.
• Patient's having dandruff (scaly scalp) even if not symptomatizing.
• Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects.
• Patients with autoimmune diseases.
• Patients with immunodeficiency diseases.
• Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum 25(OH) D3 level	6months-1 year	The serum of patients and controls will be tested by a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human 25Dihydroxy vitamin D（25-OH-D).

Trial Locations

Locations (1)

Kasr Al Ainy Teaching Hospital; 🇪🇬 Cairo, Egypt